Discussion: ‘Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder’ by Segebladh et al

Jungheim, Emily S.; Kenerson, Jessica J.; Foyouzi-Yousefi, Nastaran; Allsworth, Jenifer E.; Marquard, Kerri L.

doi:10.1016/j.ajog.2009.06.001

Cited by 5 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given that progestogen was given only for one week into a cycle in this study, it is debatable to use add-back therapy alone with estrogen. This would eliminate the effect of progestogen, which, when administered during the luteal phase, can mimic premenstrual symptoms (122). On top of this, a study by Erkkola et al indicates that progestogen supply every 3 months for 14 days was sufficient in menopausal women to prevent endometrial hyperplasia (123).…”

Section: Gnrh Agonist Treatmentmentioning

confidence: 99%

Premenstrual syndrome: new insights into etiology and review of treatment methods

Modzelewski,

Oracz,

Żukow

et al. 2024

Front. Psychiatry

View full text Add to dashboard Cite

Premenstrual syndrome (PMS) is a common disorder affecting women of reproductive age, with an estimated global prevalence of 47.8%, with severe symptoms occurring in 3-8%, significantly affecting daily functioning. GABA conductance and changes in neurosteroid levels, particularly allopregnanolone, are suspected to play a substantial role in the disorder’s etiology. In this paper, we provide an overview of recent reports on the etiology and recognized therapeutic approaches, encompassing both pharmacological and non-pharmacological interventions. Our examination includes studies on SSRIs, hormonal agents, neurosteroids, supplementation, and therapeutic roles. We aim to determine the most favorable treatment regimen by comparing medication effects and alternative methods. The treatment of PMS is crucial for enhancing the quality of life for affected women. Medications used in PMS treatment should be individually selected to achieve the best therapeutic effect, considering the clinical situation of the patients.

show abstract

Section: Gnrh Agonist Treatmentmentioning

confidence: 99%

Premenstrual syndrome: new insights into etiology and review of treatment methods

Modzelewski,

Oracz,

Żukow

et al. 2024

Front. Psychiatry

View full text Add to dashboard Cite

show abstract

Psychological/verbal abuse and utilization of mental health care in perinatal women seeking treatment for depression

Creech

Davis

Howard

et al. 2012

Arch Womens Ment Health

View full text Add to dashboard Cite

Research on psychological violence has suggested it is common among perinatal women and is predictive of later physical violence. Psychological violence is also a strong correlate of negative mental and physical health outcomes and may influence engagement in health services. Both physical and mental health care are of critical importance for perinatal women who may be especially vulnerable to psychological violence and its deleterious effects. This study examined the clinical records of 299 perinatal patients who received treatment in a psychiatric partial hospital program to determine whether there were differences in utilization of care between those women with and without current interpersonal psychological abuse. More women than expected who reported current psychological abuse left treatment early compared to those without such reports.

show abstract

Building Analytic Capacity, Facilitating Partnerships, and Promoting Data Use in State Health Agencies: A Distance-Based Workforce Development Initiative Applied to Maternal and Child Health Epidemiology

Rankin

Kroelinger

Rosenberg

et al. 2012

Matern Child Health J

View full text Add to dashboard Cite

The purpose of this article is to summarize the methodology, partnerships, and products developed as a result of a distance-based workforce development initiative to improve analytic capacity among maternal and child health (MCH) epidemiologists in state health agencies. This effort was initiated by the Centers for Disease Control's MCH Epidemiology Program and faculty at the University of Illinois at Chicago to encourage and support the use of surveillance data by MCH epidemiologists and program staff in state agencies. Beginning in 2005, distance-based training in advanced analytic skills was provided to MCH epidemiologists. To support participants, this model of workforce development included: lectures about the practical application of innovative epidemiologic methods, development of multidisciplinary teams within and across agencies, and systematic, tailored technical assistance The goal of this initiative evolved to emphasize the direct application of advanced methods to the development of state data products using complex sample surveys, resulting in the articles published in this supplement to MCHJ. Innovative methods were applied by participating MCH epidemiologists, including regional analyses across geographies and datasets, multilevel analyses of state policies, and new indicator development. Support was provided for developing cross-state and regional partnerships and for developing and publishing

show abstract

Discussion: ‘Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder’ by Segebladh et al

Cited by 5 publications

References 6 publications

Premenstrual syndrome: new insights into etiology and review of treatment methods

Premenstrual syndrome: new insights into etiology and review of treatment methods

Psychological/verbal abuse and utilization of mental health care in perinatal women seeking treatment for depression

Building Analytic Capacity, Facilitating Partnerships, and Promoting Data Use in State Health Agencies: A Distance-Based Workforce Development Initiative Applied to Maternal and Child Health Epidemiology

Contact Info

Product

Resources

About